These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 6754206)
1. Ethnic differences in drug metabolism. Kalow W Clin Pharmacokinet; 1982; 7(5):373-400. PubMed ID: 6754206 [TBL] [Abstract][Full Text] [Related]
2. Pharmacoanthropology: outline, problems, and the nature of case histories. Kalow W Fed Proc; 1984 May; 43(8):2314-8. PubMed ID: 6714439 [TBL] [Abstract][Full Text] [Related]
3. Assessment of methods to identify sources of interindividual pharmacokinetic variations. Vesell ES; Penno MB Clin Pharmacokinet; 1983; 8(5):378-409. PubMed ID: 6194927 [TBL] [Abstract][Full Text] [Related]
5. Ethnic differences in reactions to drugs and xenobiotics. Caffeine and other drugs. Kalow W Prog Clin Biol Res; 1986; 214():331-41. PubMed ID: 3523511 [TBL] [Abstract][Full Text] [Related]
6. Defective oxidation of drugs: pharmacokinetic and therapeutic implications. Eichelbaum M Clin Pharmacokinet; 1982; 7(1):1-22. PubMed ID: 7042170 [No Abstract] [Full Text] [Related]
7. The Upjohn Award Lecture 1981/La Conférence Upjohn 1981. The metabolism of xenobiotics in different populations. Kalow W Can J Physiol Pharmacol; 1982 Jan; 60(1):1-12. PubMed ID: 7039786 [No Abstract] [Full Text] [Related]
8. Molecular mechanisms of genetic polymorphisms of drug metabolism. Meyer UA; Zanger UM Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254 [TBL] [Abstract][Full Text] [Related]
9. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation. Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701 [TBL] [Abstract][Full Text] [Related]
10. Polymorphic differences in drug metabolism and response. Vetticaden SJ Methods Find Exp Clin Pharmacol; 1988 Aug; 10(8):531-6. PubMed ID: 3067018 [TBL] [Abstract][Full Text] [Related]
11. Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype. Llerena A; Cobaleda J; Martínez C; Benítez J Eur J Drug Metab Pharmacokinet; 1996; 21(2):129-38. PubMed ID: 8839686 [TBL] [Abstract][Full Text] [Related]
12. Genetic factors in hepatic drug oxidation. Kalow W; Inaba T Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542 [No Abstract] [Full Text] [Related]
13. Polymorphic drug oxidation in humans. Eichelbaum M Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436 [TBL] [Abstract][Full Text] [Related]
14. Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitro. Tyndale RF; Inaba T; Kalow W Drug Metab Dispos; 1989; 17(3):334-40. PubMed ID: 2568917 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in drug metabolism--its relevance to Asian populations. Lee EJ Ann Acad Med Singap; 1991 Jan; 20(1):56-60. PubMed ID: 2029165 [TBL] [Abstract][Full Text] [Related]
16. Pharmacoanthropology: drug metabolism. Kalow W Fed Proc; 1984 May; 43(8):2326-31. PubMed ID: 6714441 [TBL] [Abstract][Full Text] [Related]
18. [Knowledge about metabolic capacity is important in drug therapy]. Alván G; Dahl ML Lakartidningen; 1992 Feb; 89(6):382, 387-90. PubMed ID: 1738265 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Bosch TM; Meijerman I; Beijnen JH; Schellens JH Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759 [TBL] [Abstract][Full Text] [Related]
20. Effect of acute and chronic exercise on hepatic drug metabolism. Døssing M Clin Pharmacokinet; 1985; 10(5):426-31. PubMed ID: 3899456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]